Profit Investment Management’s Pfizer PFE Stock Holding History

Profit Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$289K	Hold	11,595	–	–	1.17%	30
2025 Q3	$295K	Hold	11,595	–	–	0.37%	66
2025 Q2	$281K	Hold	11,595	–	–	0.25%	69
2025 Q1	$294K	Hold	11,595	–	–	0.27%	71
2024 Q4	$308K	Hold	11,595	–	–	0.25%	75
2024 Q3	$336K	Hold	11,595	–	–	0.26%	78
2024 Q2	$324K	Hold	11,595	–	–	0.2%	75
2024 Q1	$322K	Hold	11,595	–	–	0.18%	75
2023 Q4	$334K	Hold	11,595	–	–	0.19%	73
2023 Q3	$385K	Hold	11,595	–	–	0.27%	65
2023 Q2	$425K	Buy	11,595 +4,660	+67%	+$181K	0.28%	66
2023 Q1	$283K	Hold	6,935	–	–	0.19%	72
2022 Q4	$355K	Hold	6,935	–	–	0.25%	66
2022 Q3	$303K	Hold	6,935	–	–	0.23%	69
2022 Q2	$363K	Hold	6,935	–	–	0.27%	68
2022 Q1	$359K	Hold	6,935	–	–	0.22%	72
2021 Q4	$409K	Hold	6,935	–	–	0.26%	73
2021 Q3	$298K	Hold	6,935	–	–	0.21%	74
2021 Q2	$271K	Hold	6,935	–	–	0.14%	86
2021 Q1	$252K	Hold	6,935	–	–	0.14%	85
2020 Q4	$255K	Sell	6,935 -19,352	-74%	-$710K	0.16%	84
2020 Q3	$915K	Hold	26,287	–	–	0.57%	63
2020 Q2	$816K	Hold	26,287	–	–	0.57%	62
2020 Q1	$814K	Hold	26,287	–	–	0.76%	54
2019 Q4	$977K	Hold	26,287	–	–	0.65%	62
2019 Q3	$896K	Hold	26,287	–	–	0.64%	62
2019 Q2	$1.08M	Hold	26,287	–	–	0.8%	53
2019 Q1	$1.06M	Hold	26,287	–	–	0.81%	52
2018 Q4	$1.09M	Hold	26,287	–	–	0.99%	44
2018 Q3	$1.1M	Hold	26,287	–	–	0.82%	50
2018 Q2	$905K	Hold	26,287	–	–	0.72%	56
2018 Q1	$885K	Hold	26,287	–	–	0.75%	59
2017 Q4	$903K	Hold	26,287	–	–	0.69%	59
2017 Q3	$890K	Hold	26,287	–	–	0.77%	58
2017 Q2	$838K	Hold	26,287	–	–	0.76%	59
2017 Q1	$853K	Sell	26,287 -3,288	-11%	-$104K	0.69%	61
2016 Q4	$911K	Hold	29,575	–	–	0.86%	55
2016 Q3	$950K	Sell	29,575 -19,247	-39%	-$644K	0.94%	49
2016 Q2	$1.63M	Sell	48,822 -102,781	-68%	-$3.28M	1.32%	27
2016 Q1	$4.26M	Sell	151,603 -75,320	-33%	-$2.15M	1.81%	23
2015 Q4	$6.95M	Sell	226,923 -267,080	-54%	-$8.4M	2.2%	15
2015 Q3	$14.7M	Sell	494,003 -69,421	-12%	-$2.23M	2.14%	16
2015 Q2	$17.9M	Sell	563,424 -802,839	-59%	-$26.2M	2.07%	20
2015 Q1	$45.1M	Buy	+1,366,263	New	+$43.4M	2.42%	12
2013 Q3	–	Sell	-86,208	Closed	-$2.29M	–	132
2013 Q2	$2.29M	Buy	+86,208	New	+$2.38M	0.11%	109

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Profit Investment Management's PFE Position: Q4 2025 in Review

Profit Investment Management held its Pfizer (PFE) position steady in Q4 2025 at 11,595 shares worth $289K. The position accounts for 1.17% of the portfolio, ranked #30.

Profit Investment Management first reported a position in PFE in Q2 2013 and has held it in 45 quarters since. The position peaked at $45.1M in Q1 2015. 2,913 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Profit Investment Management held 11,595 shares of Pfizer worth $289K as of Q4 2025.
Profit Investment Management left its Pfizer share count unchanged in Q4 2025.
Pfizer made up 1.17% of Profit Investment Management's portfolio in Q4 2025, its #30 holding.
Profit Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 45 quarters since.
Profit Investment Management's Pfizer position peaked at $45.1M in Q1 2015.
2,913 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Profit Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.